Chemung Financial (CHMG) opened the new reporting year with Q1 2026 results that sit against a recent run of quarterly revenue between US$23.7 million and US$29.4 million and basic EPS that has ranged from a profit of about US$1.63 to a loss of US$1.34. Over the past few quarters, the company has seen total revenue move from US$23.7 million in Q3 2024 to US$25.3 million in Q4 2024 and then to US$29.4 million in Q4 2025, while basic EPS shifted from US$1.20 to US$1.29 and then to US$1.63 over the same periods, setting the backdrop for how investors judge the latest quarter. With a trailing net profit margin of 16.7% and earnings growth concerns already in focus, the fresh numbers land in a context where compression in profitability is a key part of the story.
See our full analysis for Chemung Financial.With the headline figures in place, the next step is to weigh them against the most common narratives around Chemung Financial to see which storylines hold up and which ones the latest earnings call into question.
Curious how numbers become stories that shape markets? Explore Community Narratives
Loan book climbs toward US$2.3b
- Total loans moved from US$2,028.9 million in Q3 2024 to US$2,269.6 million by Q4 2025, with non performing loans in that period ranging between US$7.8 million and US$10.5 million.
- What stands out for a bullish view is that higher loan balances sit alongside lower non performing loans over the last twelve months. Loans were at US$2,269.6 million and non performing loans at US$7.9 million in Q4 2025, which investors can compare with earlier quarters where loans were smaller and non performing balances reached US$10.5 million.
Margins and costs find a middle ground
- On a trailing twelve month basis, net interest margin was 3.26% and the cost to income ratio was 63%. This compares with earlier trailing data points that show net interest margin at 2.76% and cost to income at 68.89% in Q4 2024.
- Bears focus on the 9.5% annual decline in trailing earnings and the net profit margin moving from 24.3% to 16.7%. However, the improvement in net interest margin from 2.76% to 3.26% and the lower cost to income ratio at 63% suggest operating spread and efficiency were not moving in the same direction as headline profitability, which gives you a more mixed picture than a simple earnings decline story.
- The 16.7% net profit margin over the last year still leaves room above many low margin businesses, even if it is below the prior 24.3% level that bears highlight.
- Cost to income moving from 68.89% to 63% on a trailing basis shows expenses consumed a smaller share of income, which partially offsets the bearish point about weaker bottom line trends.
Rich P/E meets discounted DCF fair value
- The shares trade at US$62.82 with a P/E of 20x, compared with a DCF fair value of US$95.39 and a sector context where the US Banks industry sits at 11.9x P/E and peers at 15.3x.
- What creates tension for both bullish and bearish views is that the DCF fair value suggests about a 34.1% gap between price and that estimate, while the 20x P/E is above industry and peer levels. Investors weighing the 2.16% dividend yield and the longer term 9.5% annual earnings decline have to decide whether the discounted DCF fair value or the richer earnings multiple is more important for their own valuation work.
- Bears point to the higher 20x P/E versus 11.9x for the broader US Banks industry as a sign the stock is not cheap on simple multiples, even with earnings under pressure.
- Bulls counter that a 34.1% discount to the DCF fair value and ongoing dividends at a 2.16% yield provide some support, even if earnings and margins have come down from earlier levels.
If you want to see how other investors are connecting these valuation signals, dividend income, and margin trends into a single story, Curious how numbers become stories that shape markets? Explore Community Narratives.
Next Steps
Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on Chemung Financial's growth and its valuation to see if today's price is a bargain. Add the company to your watchlist or portfolio now so you don't miss the next big move.
With both risks and rewards in the mix, it is worth taking a fresh look at the numbers yourself and deciding where you stand. If you want a quick way to frame both sides of the argument, start with these 2 key rewards and 3 important warning signs.
Explore Alternatives
Chemung Financial is working through weaker trailing earnings, a slimmer 16.7% net profit margin, and a 20x P/E that sits above many peers.
If that mix of earnings pressure and a richer valuation makes you cautious, you may wish to compare it with companies screened for pricing that looks more compelling using 59 high quality undervalued stocks.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com